CFD-d on keerulised instrumendid, millega kaasneb võimenduse tõttu suur risk kiiresti raha kaotada. 84% jaeinvestoritest kaotab selle pakkuja juures CFD-dega kaubeldes raha. Mõelge järele, kas mõistate CFD-de toimimise põhimõtet ja kas saate endale lubada riski rahast ilma jääda.
US Eesti
Riik • United States
    Üksus • The products and services listed on this website are not available in this location.
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    Ost-müük Alimera Sciences, Inc. - ALIM CFD

    2.52
    4.91%
    • Kokkuvõte
    • Ajaloolised andmed
    • Sündmused
    • Tuluaruanne
    • Bilanss
    • Rahavood
    • Omand
    Kauplemistingimused
    Hinnavahe 0.23
    Pika positsiooni ööpäeva tasu

    Long position overnight fee

    Margin. Your investment $1,000.00
    Üleöö tasu -0.025457 %
    Charges from borrowed part ($-1.02)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Mine platvormile
    		-0.025457%
    Lühikese positsiooni ööpäeva tasu

    Short position overnight fee

    Margin. Your investment $1,000.00
    Üleöö tasu 0.003235 %
    Charges from borrowed part ($0.13)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Mine platvormile
    		0.003235%
    Ööpäeva tasu aeg 21:00 (UTC)
    Min kauplemise kogus 1
    Valuuta USD
    Tagatis 20%
    Aktsiabörs United States of America
    Kauplemise vahendustasu 0%

    *Information provided by Capital.com

    Võtmestatistika
    Eelmine sulgemine* 2.65
    Avatud* 2.6
    Aastane muutus* -54.14%
    Päeva ulatus* 2.51 - 2.6
    52 nädala ulatus 1.30-7.92
    Keskmine maht (10 päeva) 3.73M
    Keskmine maht (3 kuud) 12.89M
    Turukapitalisatsioon 19.59M
    P/E suhtarv -100.00K
    Ringluses olevad aktsiad 7.40M
    Tulu 55.78M
    EPS -2.44
    Dividendid (% kasumist) N/A
    Beeta 1.40
    Järgmine tuluaruande kuupäev Jul 25, 2023

    Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Sulgemishind Change (%) Avamishind High Low
    May 31, 2023 2.67 0.19 7.66% 2.48 2.67 2.48
    May 30, 2023 2.52 0.05 2.02% 2.47 2.55 2.47
    May 26, 2023 2.49 0.08 3.32% 2.41 2.52 2.35
    May 25, 2023 2.48 -0.02 -0.80% 2.50 2.51 2.37
    May 24, 2023 2.41 0.23 10.55% 2.18 2.42 2.14
    May 23, 2023 2.32 -0.19 -7.57% 2.51 2.55 2.21
    May 22, 2023 2.45 0.28 12.90% 2.17 2.72 2.15
    May 19, 2023 2.23 0.12 5.69% 2.11 2.30 2.02
    May 18, 2023 2.34 -0.26 -10.00% 2.60 3.05 2.26
    May 17, 2023 1.93 0.11 6.04% 1.82 1.94 1.78
    May 16, 2023 1.79 0.21 13.29% 1.58 1.92 1.58
    May 15, 2023 1.57 -0.03 -1.88% 1.60 1.68 1.56
    May 12, 2023 1.56 -0.05 -3.11% 1.61 1.64 1.55
    May 11, 2023 1.57 0.02 1.29% 1.55 1.64 1.48
    May 10, 2023 1.52 -0.11 -6.75% 1.63 1.85 1.51
    May 9, 2023 1.63 -0.14 -7.91% 1.77 1.77 1.63
    May 8, 2023 1.73 -0.06 -3.35% 1.79 1.80 1.73
    May 5, 2023 1.83 -0.05 -2.66% 1.88 2.04 1.76
    May 4, 2023 1.84 0.10 5.75% 1.74 1.85 1.69
    May 3, 2023 1.69 0.01 0.60% 1.68 1.78 1.66

    Alimera Sciences, Inc. Events

    Kellaaeg (UTC) (UTC) Riik Sündmus
    Wednesday, July 12, 2023

    Kellaaeg (UTC) (UTC)

    13:30

    Riik

    US

    Sündmus

    Alimera Sciences Inc Annual Shareholders Meeting
    Alimera Sciences Inc Annual Shareholders Meeting

    Forecast

    -

    Previous

    -
    Tuesday, July 25, 2023

    Kellaaeg (UTC) (UTC)

    12:30

    Riik

    US

    Sündmus

    Q2 2023 Alimera Sciences Inc Earnings Release
    Q2 2023 Alimera Sciences Inc Earnings Release

    Forecast

    -

    Previous

    -
    Monday, November 13, 2023

    Kellaaeg (UTC) (UTC)

    13:30

    Riik

    US

    Sündmus

    Q3 2023 Alimera Sciences Inc Earnings Release
    Q3 2023 Alimera Sciences Inc Earnings Release

    Forecast

    -

    Previous

    -
    Vaadake kõiki sündmusi
    • Aastas
    • Kvartalis
    2022 2021 2020 2019 2018
    Kogutulu 54.129 59.029 50.82 53.943 46.599
    Tulu 54.129 59.029 50.82 53.943 46.599
    Kulud, Kokku 7.977 7.03 6.941 6.626 4.308
    Brutokasum 46.152 51.999 43.879 47.317 42.291
    Kogu tegevuskulu 65.769 57.438 51.321 59.217 58.035
    Müük/Üldine/admin kulud, kokku 38.858 35.843 32.036 38.958 38.042
    Uuringud ja arendus 16.228 13.778 9.668 10.992 11.274
    Depreciation / Amortization 2.706 2.579 2.676 2.641 2.645
    Ootamatud kulutused (tulu) 0 -1.792 0 1.766
    Tulud majandustegevusest -11.64 1.591 -0.501 -5.274 -11.436
    Intressitulud (kulu), muud tulud, neto -5.789 -4.997 -4.906 -4.953 -4.84
    Netotulu enne makse -18.079 -3.934 -5.407 -10.227 -16.276
    Netotulu pärast makse -18.107 -4.372 -5.339 -10.443 -16.382
    Netotulu enne erikulusid -18.107 -4.372 -5.339 -10.443 -16.382
    Netotulu -18.107 -4.372 -5.339 -10.443 -16.382
    Arvestatav tulu, v a erikulud -18.107 -4.372 -5.339 -10.443 21.948
    Arvestatav tulu, koos erikuludega -18.107 -4.372 -5.339 -10.443 21.948
    Jaotamisele kuuluv netotulu -18.107 -4.372 -5.339 -10.443 21.948
    Keskmine jaotamisele kuuluv aktsia kohta 6.99685 6.59524 5.11766 4.7702 5.91587
    Jaotatav EPS, v a erakorralised kulud -2.58788 -0.6629 -1.04325 -2.18921 3.71002
    Jaotamisele kuuluv normaal-EPS -2.58788 -0.83951 -1.04325 -2.18921 3.90406
    Other Operating Expenses, Total
    Erakorralised kulud kokku 0 0
    Total Adjustments to Net Income 0 38.33
    Muud, neto -0.65 -0.528
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Kogutulu 13.546 14.029 13.598 14.604 11.898
    Tulu 13.546 14.029 13.598 14.604 11.898
    Kulud, Kokku 2.028 2.125 2.006 2.166 1.68
    Brutokasum 11.518 11.904 11.592 12.438 10.218
    Kogu tegevuskulu 16.848 16.137 17.009 16.578 16.045
    Müük/Üldine/admin kulud, kokku 9.975 9.099 9.856 9.81 10.093
    Uuringud ja arendus 4.164 4.23 4.483 3.932 3.583
    Depreciation / Amortization 0.681 0.683 0.664 0.67 0.689
    Tulud majandustegevusest -3.302 -2.108 -3.411 -1.974 -4.147
    Intressitulud (kulu), muud tulud, neto -1.68 -1.621 -1.567 -1.345 -1.256
    Netotulu enne makse -4.968 -3.781 -5.245 -3.098 -5.955
    Netotulu pärast makse -4.968 -3.78 -5.257 -3.115 -5.955
    Netotulu enne erikulusid -4.968 -3.78 -5.257 -3.115 -5.955
    Netotulu -4.968 -3.78 -5.257 -3.115 -5.955
    Arvestatav tulu, v a erikulud -4.982 -3.78 -5.257 -3.115 -5.955
    Arvestatav tulu, koos erikuludega -4.982 -3.78 -5.257 -3.115 -5.955
    Jaotamisele kuuluv netotulu -4.982 -3.78 -5.257 -3.115 -5.955
    Keskmine jaotamisele kuuluv aktsia kohta 7.03223 7.00032 6.99658 6.99971 6.99074
    Jaotatav EPS, v a erakorralised kulud -0.70845 -0.53998 -0.75137 -0.44502 -0.85184
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Jaotamisele kuuluv normaal-EPS -0.70845 -0.53998 -0.75137 -0.44502 -0.85184
    Ootamatud kulutused (tulu) 0 0 0
    Muud, neto 0.014 -0.052 -0.267 0.221 -0.552
    Total Adjustments to Net Income -0.014
    • Aastas
    • Kvartalis
    2022 2021 2020 2019 2018
    Käibevarad kokku 29.413 42.16 34.906 32.745 34.848
    Raha ja lühiajalised investeeringud 5.274 16.51 11.208 9.426 13.043
    Raha ja ekvivalendid 5.274 16.51 11.208 9.426 13.043
    Laekumata arved, neto 19.612 19.128 17.2 19.331 17.259
    Accounts Receivable - Trade, Net 19.612 19.128 17.2 19.331 17.259
    Total Inventory 1.605 2.679 2.746 1.39 2.405
    Prepaid Expenses 2.892 3.809 3.718 2.565 2.109
    Other Current Assets, Total 0.03 0.034 0.034 0.033 0.032
    Total Assets 42.602 58.52 50.855 50.309 54.108
    Property/Plant/Equipment, Total - Net 3.92 4.493 2.358 2.047 1.355
    Property/Plant/Equipment, Total - Gross 7.981 7.923 6.305 5.858 4.967
    Accumulated Depreciation, Total -4.061 -3.43 -3.947 -3.881 -3.612
    Intangibles, Net 8.957 10.897 12.838 14.783 16.723
    Other Long Term Assets, Total 0.129 0.137 0.753 0.734 1.182
    Total Current Liabilities 39.732 12.592 12.348 12.048 10.234
    Accounts Payable 10.088 8.706 7.461 7.077 6.355
    Accrued Expenses 3.998 3.617 3.197 4.716 3.643
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 25.646 0.269 1.69 0.255 0.236
    Other Current Liabilities, Total
    Total Liabilities 63.41 61.125 58.833 54.754 51.386
    Total Long Term Debt 18.683 43.08 42.922 38.752 38.178
    Long Term Debt 18.683 43.08 42.408 38.658 37.873
    Capital Lease Obligations 0.514 0.094 0.305
    Other Liabilities, Total 4.995 5.453 3.563 3.954 2.974
    Total Equity -20.808 -2.605 -7.978 -4.445 2.722
    Preferred Stock - Non Redeemable, Net 19.227 19.227 19.227 30.344 30.344
    Common Stock 0.07 0.069 0.057 0.05 0.701
    Additional Paid-In Capital 378.238 377.229 365.83 350.117 346.108
    Retained Earnings (Accumulated Deficit) -415.388 -397.281 -392.539 -383.863 -373.42
    Other Equity, Total -2.955 -1.849 -0.553 -1.093 -1.011
    Total Liabilities & Shareholders’ Equity 42.602 58.52 50.855 50.309 54.108
    Total Common Shares Outstanding 6.99551 6.93515 5.71937 4.96595 4.67193
    Total Preferred Shares Outstanding 0.6 0.6 0.6 0.61015 0.61015
    Long Term Investments 0.183 0.833
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Käibevarad kokku 35.675 29.413 29.76 33.073 34.753
    Raha ja lühiajalised investeeringud 13.086 5.274 5.514 7.859 9.946
    Raha ja ekvivalendid 13.086 5.274 5.514 7.859 9.946
    Laekumata arved, neto 18.433 19.612 19.142 20.319 18.776
    Accounts Receivable - Trade, Net 18.433 19.612 19.142 20.319 18.776
    Total Inventory 1.215 1.605 1.786 1.656 2.452
    Prepaid Expenses 2.91 2.892 3.29 3.208 3.546
    Other Current Assets, Total 0.031 0.03 0.028 0.031 0.033
    Total Assets 48.239 42.602 43.429 47.574 49.931
    Property/Plant/Equipment, Total - Net 3.757 3.92 3.87 3.938 4.343
    Intangibles, Net 8.479 8.957 9.446 9.935 10.419
    Other Long Term Assets, Total 0.131 0.129 0.118 0.126 0.134
    Total Current Liabilities 14.173 39.732 34.01 25.431 17.006
    Accounts Payable 9.669 10.088 8.706 7.614 6.604
    Accrued Expenses 4.241 3.998 3.661 3.316 3.046
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0.263 25.646 21.643 14.501 7.356
    Total Liabilities 67.155 63.41 61.507 59.909 58.534
    Total Long Term Debt 44.312 18.683 22.492 29.297 36.245
    Long Term Debt 44.152 18.683 22.492 29.297 36.245
    Capital Lease Obligations 0.16
    Other Liabilities, Total 8.67 4.995 5.005 5.181 5.283
    Total Equity -18.916 -20.808 -18.078 -12.335 -8.603
    Preferred Stock - Non Redeemable, Net 7.728 19.227 19.227 19.227 19.227
    Common Stock 0.074 0.07 0.07 0.07 0.07
    Additional Paid-In Capital 378.146 378.238 378.005 377.847 377.541
    Retained Earnings (Accumulated Deficit) -402.081 -415.388 -411.608 -406.351 -403.236
    Other Equity, Total -2.783 -2.955 -3.772 -3.128 -2.205
    Total Liabilities & Shareholders’ Equity 48.239 42.602 43.429 47.574 49.931
    Total Common Shares Outstanding 7.39159 6.99551 6.99802 6.99546 6.99265
    Total Preferred Shares Outstanding 0.012 0.6 0.6 0.6 0.6
    Long Term Investments 0.197 0.183 0.235 0.502 0.282
    Other Current Liabilities, Total
    • Aastas
    • Kvartalis
    2022 2021 2020 2019 2018
    Netotulu/algväärtus -18.107 -4.372 -5.339 -10.443 -16.382
    Raha majandustegevusest -9.975 -3.224 -2.193 -4.152 -11.553
    Raha majandustegevusest 2.706 2.579 2.676 2.641 2.645
    Deferred Taxes 0.116 0.61 0.031 0.454 -0.653
    Mittelikviidsed varad 2.621 -0.692 1.829 3.377 7.084
    Cash Taxes Paid 0.232 0.112 0.11 0.239 0.239
    Makstud intressid 4.489 4.302 4.556 4.419 3.571
    Muutused tööjõus 2.689 -1.349 -1.39 -0.181 -4.247
    Tulu investeeringutelt -0.255 -0.621 -0.62 -0.174 -0.175
    Kapitalikulutused -0.255 -0.621 -0.62 -0.174 -0.175
    Rahavood investeeringutelt -0.302 9.823 3.882 0.869 0.95
    Rahavoogudesse investeerimine -0.113 0 -0.019 -2.227 -3.808
    Aktsiate emiteerimine (tagasiost), neto 0.1 10.044 0.049 0.902 0.085
    Laenu väljastamine (kustutamine), neto -0.289 -0.221 3.852 2.194 4.673
    Muutused valuutakursside kõikumisest -0.708 -0.676 0.714 -0.159 -0.248
    Rahaline kogumuutus -11.24 5.302 1.783 -3.616 -11.026
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -4.968 -18.107 -14.327 -9.07 -5.955
    Cash From Operating Activities -2.209 -9.975 -9.724 -7.811 -6.213
    Cash From Operating Activities 0.681 2.706 2.023 1.359 0.689
    Non-Cash Items 0.507 2.621 2.095 1.318 1.027
    Cash Taxes Paid 0 0.232 0.224 0.182 0.018
    Cash Interest Paid 1.354 4.489 3.253 2.145 1.061
    Changes in Working Capital 1.571 2.689 0.485 -1.418 -1.974
    Cash From Investing Activities -0.009 -0.255 -0.171 -0.041 -0.149
    Capital Expenditures -0.009 -0.255 -0.171 -0.041 -0.149
    Cash From Financing Activities 9.998 -0.302 -0.109 -0.164 -0.062
    Financing Cash Flow Items -3.123 -0.113
    Issuance (Retirement) of Debt, Net 2.373 -0.289 -0.164 -0.204 -0.062
    Foreign Exchange Effects 0.033 -0.708 -0.998 -0.638 -0.141
    Net Change in Cash 7.813 -11.24 -11.002 -8.654 -6.565
    Issuance (Retirement) of Stock, Net 10.748 0.1 0.055 0.04
    Deferred Taxes 0.116
    Investori nimi Investori liik Ringluse protsent Hoitud osakud Muutus osakutes Hoidmise kuupäev Hinnang käibele
    Velan Capital Investment Management LP Investment Advisor/Hedge Fund 22.4131 1659654 1401901 2023-05-17 MED
    Ocumension Therapeutics Corporation 15.4621 1144945 0 2023-04-24 LOW
    Morgan Stanley & Co. LLC Research Firm 8.9243 660832 0 2023-03-31 MED
    Caligan Partners, LP Hedge Fund 6.4657 478777 0 2023-05-17 MED
    Eiswirth (Richard S Jr) Individual Investor 4.3555 322518 500 2023-04-24 LOW
    HOOPP Investment Management Pension Fund 3.3762 250000 0 2023-03-31 HIGH
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.0071 148624 0 2023-03-31 LOW
    Ashman Philip Individual Investor 1.8004 133315 0 2023-04-24 MED
    Holland (David R) Individual Investor 1.4704 108880 500 2023-04-24 LOW
    Renaissance Technologies LLC Hedge Fund 1.3693 101394 -1100 2023-03-31 HIGH
    Skibsted (Russell L) Individual Investor 1.0196 75500 58000 2023-03-26 HIGH
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.5167 38262 0 2023-03-31 LOW
    Jones (John Philip) Individual Investor 0.4347 32186 372 2022-10-31
    Millennium Management LLC Hedge Fund 0.3884 28762 16799 2023-03-31 HIGH
    Acadian Asset Management LLC Investment Advisor/Hedge Fund 0.2639 19542 0 2023-03-31 MED
    Bridgeway Capital Management, LLC Investment Advisor 0.2471 18300 0 2023-03-31 LOW
    Perritt Capital Management, Inc. Investment Advisor 0.2431 18000 0 2023-03-31 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 0.175 12962 438 2023-03-31 LOW
    J.P. Morgan Securities LLC Research Firm 0.14 10364 9838 2023-03-31 MED
    Snisarenko (John) Individual Investor 0.135 10000 0 2023-04-24 LOW

    Miks valida Capital.com? Meie numbrid räägivad iseenda eest.

    Capital.com Group

    535K+

    Kauplejad

    87K+

    Igakuiste aktiivsete klientide arv

    $113M+

    Igakuine investeerimise maht

    $64M+

    Igakuiselt välja võetud

    Kauplemiskalkulaator

    Arvutage oma hüpoteetiline võit/kaotus, kui oleksite avanud CFD-tehingu ühel kindlal kuupäeval (valige kuupäev) ja sulgenud teisel kuupäeval (valige kuupäev).

    Kauplemise vahendustasu
    0
    • 1:1
    Finantsvõimendus
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investeering
    Tehingu suurus (võimendus x investeering):
    Avamishind

    Close

    Lühike Pikk
    Varasem tootlikkus ei ole tuleviku tulemuste hindamiseks usaldusväärne indikaator
    Kasum/Kaotus

    Alimera Sciences, Inc. Company profile

    Ettevõttest Alimera Sciences, Inc.

    Alimera Sciences, Inc. on farmaatsiaettevõte. Ettevõte tegeleb retsepti alusel väljastatavate silmaravimite turustamise ja arendamisega. See keskendub silma tagakülge ehk võrkkesta mõjutavatele haigustele. Ettevõtte kaubanduslik toode ILUVIEN on intravitreaalne implantaat, mis ravib patsiente, manustades silma kuni 36 kuu jooksul pidevat mikrodoosi ravimiteta kortikosteroidi fluotsinoloonatsetoniidi (FAc). Ettevõte tegeleb diabeetilise makulaödeemi (DME) ravi arendamisega. DME on võrkkesta haigus, mis mõjutab diabeeti põdevaid inimesi ja võib põhjustada tõsist nägemise kaotust ja pimedaks jäämist. ILUVIENi saab kasutada ka tagumise silma tagumise segmendi (NIU-PS) retsidiivse mitteinfektsioosse uveiidi ägenemise vältimiseks. Ettevõte turustab ILUVIENi otse Ameerika Ühendriikides, Saksamaal, Ühendkuningriigis, Portugalis ja Iirimaal.

    Industry: Biopharmaceuticals

    Ste 290
    6120 Windward Parkway
    ALPHARETTA
    GEORGIA 30005
    US

    Tuluaruanne

    • Annual
    • Quarterly

    Teised on vaadanud veel

    Oil - Crude

    70.20 Price
    +3.700% 1D Chg, %
    Pika positsiooni ööpäeva tasu -0.0204%
    Lühikese positsiooni ööpäeva tasu -0.0016%
    Ööpäeva tasu aeg 21:00 (UTC)
    Hinnavahe 0.03

    BTC/USD

    26,812.80 Price
    -1.390% 1D Chg, %
    Pika positsiooni ööpäeva tasu -0.0616%
    Lühikese positsiooni ööpäeva tasu 0.0137%
    Ööpäeva tasu aeg 21:00 (UTC)
    Hinnavahe 60.00

    Gold

    1,976.06 Price
    +0.690% 1D Chg, %
    Pika positsiooni ööpäeva tasu -0.0183%
    Lühikese positsiooni ööpäeva tasu 0.0101%
    Ööpäeva tasu aeg 21:00 (UTC)
    Hinnavahe 0.30

    US100

    14,447.50 Price
    +1.410% 1D Chg, %
    Pika positsiooni ööpäeva tasu -0.0255%
    Lühikese positsiooni ööpäeva tasu 0.0032%
    Ööpäeva tasu aeg 21:00 (UTC)
    Hinnavahe 1.8

    Kas otsite jätkuvalt vahendajat, keda saab usaldada?

    Ühinege 535,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com

    1. Looge ja kinnitage oma konto 2. Tee sissemakse 3. Alusta kauplemist